Allianz Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.49M | Sell |
7,100
-2,500
| -26% | -$1.36M | ﹤0.01% | 1331 |
|
|
2025
Q4 | $5.56M | Sell |
9,600
-1,100
| -10% | -$622K | 0.01% | 1090 |
|
|
2025
Q3 | $5.19M | Buy |
10,700
+5,400
| +102% | +$2.51M | 0.01% | 1105 |
|
|
2025
Q2 | $2.15M | Sell |
5,300
-7,400
| -58% | -$3.09M | ﹤0.01% | 1451 |
|
|
2025
Q1 | $6.32M | Buy |
12,700
+6,900
| +119% | +$3.74M | 0.01% | 990 |
|
|
2024
Q4 | $3.02M | Buy |
5,800
+4,500
| +346% | +$2.47M | ﹤0.01% | 1263 |
|
|
2024
Q3 | $804K | Buy |
1,300
+200
| +18% | +$118K | ﹤0.01% | 1707 |
|
|
2024
Q2 | $608K | Buy |
1,100
+800
| +267% | +$458K | ﹤0.01% | 1772 |
|
|
2024
Q1 | $174K | Sell |
300
-7,100
| -96% | -$3.98M | ﹤0.01% | 1864 |
|
|
2023
Q4 | $3.93M | Sell |
7,400
-10,200
| -58% | -$4.94M | 0.01% | 1039 |
|
|
2023
Q3 | $8.91M | Buy |
17,600
+10,800
| +159% | +$5.76M | 0.02% | 759 |
|
|
2023
Q2 | $3.55M | Sell |
6,800
-5,000
| -42% | -$2.7M | 0.01% | 1005 |
|
|
2023
Q1 | $6.8M | Sell |
11,800
-10,100
| -46% | -$5.69M | 0.01% | 847 |
|
|
2022
Q4 | $12.1M | Buy |
21,900
+5,200
| +31% | +$2.76M | 0.02% | 624 |
|
|
2022
Q3 | $8.47M | Buy |
16,700
+6,800
| +69% | +$3.81M | 0.02% | 709 |
|
|
2022
Q2 | $5.38M | Buy |
9,900
+5,000
| +102% | +$2.75M | 0.01% | 1074 |
|
|
2022
Q1 | $2.89M | Sell |
4,900
-3,800
| -44% | -$2.18M | ﹤0.01% | 1453 |
|
|
2021
Q4 | $5.8M | Sell |
8,700
-11,100
| -56% | -$6.93M | ﹤0.01% | 1172 |
|
|
2021
Q3 | $11.3M | Buy |
19,800
+14,800
| +296% | +$8.12M | 0.01% | 970 |
|
|
2021
Q2 | $2.52M | Buy |
+5,000
| New | +$2.36M | ﹤0.01% | 1381 |
|
|
2020
Q3 | – | Sell |
-9,000
| Closed | -$3.26M | – | 2377 |
|
|
2020
Q2 | $3.26M | Sell |
9,000
-7,600
| -46% | -$2.55M | ﹤0.01% | 1392 |
|
|
2020
Q1 | $4.71M | Sell |
16,600
-23,200
| -58% | -$7.32M | 0.01% | 1185 |
|
|
2019
Q4 | $12.9M | Buy |
39,800
+6,100
| +18% | +$1.85M | 0.01% | 993 |
|
|
2019
Q3 | $9.82M | Sell |
33,700
-2,700
| -7% | -$773K | 0.01% | 1130 |
|
|
2019
Q2 | $10.7M | Buy |
36,400
+3,700
| +11% | +$1.02M | 0.01% | 1166 |
|
|
2019
Q1 | $8.95M | Buy |
32,700
+14,200
| +77% | +$3.53M | 0.01% | 1189 |
|
|
2018
Q4 | $4.14M | Sell |
18,500
-2,100
| -10% | -$493K | ﹤0.01% | 1483 |
|
|
2018
Q3 | $5.03M | Sell |
20,600
-3,800
| -16% | -$874K | ﹤0.01% | 1557 |
|
|
2018
Q2 | $5.05M | Buy |
24,400
+2,200
| +10% | +$467K | ﹤0.01% | 1516 |
|
|
2018
Q1 | $4.58M | Sell |
22,200
-72,700
| -77% | -$15.3M | ﹤0.01% | 1570 |
|
|
2017
Q4 | $18M | Buy |
94,900
+6,200
| +7% | +$1.19M | 0.01% | 1034 |
|
|
2017
Q3 | $16.8M | Buy |
88,700
+17,500
| +25% | +$3.17M | 0.01% | 1062 |
|
|
2017
Q2 | $12.4M | Sell |
71,200
-8,200
| -10% | -$1.38M | 0.01% | 1216 |
|
|
2017
Q1 | $12.2M | Sell |
79,400
-29,500
| -27% | -$4.51M | 0.01% | 1245 |
|
|
2016
Q4 | $15.4M | Buy |
108,900
+26,600
| +32% | +$3.92M | 0.01% | 1166 |
|
|
2016
Q3 | $13.1M | Buy |
82,300
+28,300
| +52% | +$4.36M | 0.01% | 1195 |
|
|
2016
Q2 | $7.98M | Buy |
54,000
+24,100
| +81% | +$3.56M | 0.01% | 1324 |
|
|
2016
Q1 | $4.23M | Buy |
29,900
+13,000
| +77% | +$1.74M | ﹤0.01% | 1514 |
|
|
2015
Q4 | $2.4M | Buy |
16,900
+9,700
| +135% | +$1.29M | ﹤0.01% | 1641 |
|
|
2015
Q3 | $880K | Sell |
7,200
-16,800
| -70% | -$2.19M | ﹤0.01% | 1886 |
|
|
2015
Q2 | $3.11M | Buy |
24,000
+11,400
| +90% | +$1.49M | ﹤0.01% | 1536 |
|
|
2015
Q1 | $1.69M | Sell |
12,600
-9,800
| -44% | -$1.26M | ﹤0.01% | 1597 |
|
|
2014
Q4 | $2.81M | Buy |
22,400
+17,900
| +398% | +$2.18M | ﹤0.01% | 1418 |
|
|
2014
Q3 | $548K | Buy |
+4,500
| New | +$547K | ﹤0.01% | 1870 |
|
Other funds holding TMO
VCM
Allianz Asset Management's TMO Position: Q1 2026 in Review
Allianz Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $58.8M and leaving 418,106 shares worth $206M. The position accounts for 0.22% of the portfolio, ranked #91.
Allianz Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Allianz Asset Management held 418,106 shares of Thermo Fisher Scientific worth $206M as of Q1 2026.
- Allianz Asset Management sold 108,291 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.8M.
- Thermo Fisher Scientific made up 0.22% of Allianz Asset Management's portfolio in Q1 2026, its #91 holding.
- Allianz Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Thermo Fisher Scientific position peaked at $1.01B in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.